ArticleKidney medicine2025
Acute Kidney Failure in Limited Scleroderma Reveals Anti-GBM--Associated Kidney Disease.
Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although scleroderma renal crisis (SRC) is the most common form of kidney injury in patients with scleroderma, consideration of other autoimmune conditions is warranted in patients with atypical presentation. A 27-year-old woman with a history of limited scleroderma presented to the hospital with 1 month of uremic symptoms and oliguria. Initial laboratory tests revealed significantly elevated serum urea nitrogen and creatinine levels, suggesting kidney failure. Suspicion for SRC was low, and kidney biopsy was performed to evaluate further. Histopathology revealed severe diffuse crescentic glomerulonephritis involving almost all glomeruli. Immunofluorescence revealed a diffuse linear reaction for immunoglobulin G along capillary loop basement membranes, consistent with antiglomerular basement membrane (GBM) disease. Further work-up revealed a positive antineutrophil cytoplasmic antibody panel for antimyeloperoxidase antibodies. Anti-GBM levels were also elevated. Treatment for anti-GBM disease was not warranted in our patient as the severity of kidney injury histopathology suggested unlikely kidney recovery. She was initiated on outpatient dialysis, and discussion regarding kidney transplant was initiated. There is a rare association between scleroderma and anti-GBM disease. Anti-GBM disease should be considered in scleroderma patients presenting with acute kidney failure with atypical features for SRC, especially if they have a history of antineutrophil cytoplasmic antibody positivity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.